Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Corrado Vitale"'
Autor:
Martino Marangella, Piergiuseppe Daniele, Michele Petrarulo, Corrado Vitale, Silvio Sammartano
Publikováno v:
Urolithiasis. 49:211-217
Estimation of state of saturation with stone-forming salt represents a reliable tool to assess the overall risk. The available methods are based on computer-assisted ab initio calculations. Our earlier method URSUS was subsequently substituted by Lit
Publikováno v:
World Journal of Urology. 39:597-603
In this paper, we investigated whether cholecalciferol supplementation may increase the risk of stone recurrence in patients with calcium nephrolithiasis and Vitamin D deficiency. Thirty-three stone formers (56 ± 17 years old, 12 males) with 25(OH)D
Autor:
Pasquale Strazzullo, Pietro Manuel Ferraro, Miguel Angel Arrabal-Polo, Agnieszka Pozdzik, Ewout J. Hoorn, Christian Seitz, Liffert Vogt, Emanuele Croppi, Kremena Petkova, Emmanuel Letavernier, Daniel Guido Fuster, Giovanni Gambaro, Felix Knauf, Shabbir H. Moochhala, Nilufar Mohebbi, John A. Sayer, Adamasco Cupisti, Giuseppe Vezzoli, Alberto Trinchieri, Giovambattista Capasso, Felix Grases, Robert J. Unwin, Corrado Vitale, Juan Antonio Galan, Thomas Ernandez, Olivier Bonny
Publikováno v:
Urolithiasis. Springer Verlag
Ferraro, Pietro Manuel; Arrabal-Polo, Miguel Ángel; Capasso, Giovambattista; Croppi, Emanuele; Cupisti, Adamasco; Ernandez, Thomas; Fuster, Daniel Guido; Galan, Juan Antonio; Grases, Felix; Hoorn, Ewout J; Knauf, Felix; Letavernier, Emmanuel; Mohebbi, Nilufar; Moochhala, Shabbir; Petkova, Kremena; Pozdzik, Agnieszka; Sayer, John; Seitz, Christian; Strazzullo, Pasquale; Trinchieri, Alberto; ... (2019). A preliminary survey of practice patterns across several European kidney stone centers and a call for action in developing shared practice. Urolithiasis, 47(3), pp. 219-224. Springer 10.1007/s00240-019-01119-z
Urolithiasis
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
instname
Urolithiasis, 47(3), 219-224. Springer-Verlag
Ferraro, Pietro Manuel; Arrabal-Polo, Miguel Ángel; Capasso, Giovambattista; Croppi, Emanuele; Cupisti, Adamasco; Ernandez, Thomas; Fuster, Daniel Guido; Galan, Juan Antonio; Grases, Felix; Hoorn, Ewout J; Knauf, Felix; Letavernier, Emmanuel; Mohebbi, Nilufar; Moochhala, Shabbir; Petkova, Kremena; Pozdzik, Agnieszka; Sayer, John; Seitz, Christian; Strazzullo, Pasquale; Trinchieri, Alberto; ... (2019). A preliminary survey of practice patterns across several European kidney stone centers and a call for action in developing shared practice. Urolithiasis, 47(3), pp. 219-224. Springer 10.1007/s00240-019-01119-z
Urolithiasis
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
instname
Urolithiasis, 47(3), 219-224. Springer-Verlag
Currently an evidence-based approach to nephrolithiasis is hampered by a lack of randomized controlled trials. Thus, there is a need for common platforms for data sharing and recruitment of patients to interventional studies. A first step in achievin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4238aaad1e213e93bdfb27594e6abf4b
https://pure.amc.nl/en/publications/a-preliminary-survey-of-practice-patterns-across-several-european-kidney-stone-centers-and-a-call-for-action-in-developing-shared-practice(70be26c6-f777-4dfb-918e-728c6af87145).html
https://pure.amc.nl/en/publications/a-preliminary-survey-of-practice-patterns-across-several-european-kidney-stone-centers-and-a-call-for-action-in-developing-shared-practice(70be26c6-f777-4dfb-918e-728c6af87145).html
Autor:
Cristiana Bagnis, Adriano Ramello, Martino Marangella, Corrado Vitale, Michele Petrarulo, Michele Bruno
Publikováno v:
Urologia Internationalis. 72:6-10
It is currently agreed that stone formation in the urinary tract requires supersaturation with respect to a given solid phase. However, this principle fully applies only to stones other than calcium-containing stones, in which case compounds acting a
Publikováno v:
American Journal of Kidney Diseases. 19:546-553
Primary hyperoxaluria type I (PH1) always leads to end-stage renal failure (ESRF) due to deposition of calcium oxalate in the kidney. Regular dialysis therapy (RDT) can not overcome the excess production of oxalate, hence, systemic oxalate deposition
Autor:
Martino Marangella, Franco Linari, Corrado Vitale, Pietro Finocchiaro, Ornella Bianco, Michele Petrarulo
Publikováno v:
Kidney International. 39:149-154
Glycolate determination detects type I primary hyperoxaluria in dialysis patients. The detection of type I primary hyperoxaluria is based on the finding of exceedingly high oxalate excretion which is associated with increased glycolate excretion. The
Autor:
Giovanni Muto, Martino Marangella, Corrado Vitale, Michele Petrarulo, Leonardo D'Urso, Franco Bardari, Andrea Formiconi
Publikováno v:
BJU international. 101(12)
OBJECTIVE To investigate metabolic disturbances, possibly leading to stone disease, in the Camey II technique for creating a urinary reservoir from an intestinal segment. PATIENTS, SUBJECTS AND METHODS Thirty patients with a Camey II ileal neobladder
Glycolate and Oxalate Plasma Levels and Renal Handling in Patients With Type 1 Primary Hyperoxaluria
Publikováno v:
Urolithiasis 2 ISBN: 9781461360919
Detection and differentiation of primary hyperoxaluria type: (PH1) is based on the finding of high urine levels of both oxalate and glycolate. However, these assays may produce misleading results when PH1 is associated with chronic renal failure (CRF
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1121b5d439bc206a1d63841d8c0282a4
https://doi.org/10.1007/978-1-4615-2556-1_16
https://doi.org/10.1007/978-1-4615-2556-1_16
Publikováno v:
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 8(12)
Systemic oxalosis is a constant feature in patients with primary hyperoxaluria type 1 (PH1) and chronic renal failure (CRF) and is not prevented by regular dialysis (RDT), because removal cannot keep up with retention and overproduction of oxalate. T
Publikováno v:
The Journal of urology. 148(3 Pt 2)
To differentiate hyperoxaluria syndromes we measured plasma and urine glycolate by a novel high performance liquid chromatographic procedure. Mean glycolate level was 7.9 +/- 2.4 mumol./l. in plasma and 422 +/- 137 mumol./24 hours in urine from 19 co